“…Previous studies showed a correlation between endpoints, such as CYPlAl induction, and affinity for the Ah receptor expressed through SARs (25). For example, in this study 2,3,7,8-TCDD, PCB 126, and 4-PeCDF, the congeners that increased endometriotic lesion diameters (statistically significant only in animals treated with 2,3,7,8-TCDD or 4-PeCDF), have the strongest binding affinities for the Ah receptor (1,26,27). In contrast, compounds such as 1,3,6,8-TCDD and PCB 153, which did not induce any increases in endometriotic lesion diameter, have weak affinities towards the Ah receptor (27,28).…”